Technical Analysis for AMPH - Amphastar Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 19.93 -2.88% -0.59
AMPH closed down 2.88 percent on Friday, October 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AMPH trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
BB Squeeze Started Range Contraction 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.88%
Stochastic Reached Overbought Strength -2.88%
Weak + Overbought Other -2.88%
Inside Day Range Contraction -2.88%
Overbought Stochastic Strength -2.88%
Upper Bollinger Band Touch Strength -2.88%

Older signals for AMPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of generic and proprietary pharmaceuticals, delivery systems, and active pharmaceutical ingredients. The company focuses on injectable, inhalation, and other categories of pharmaceutical products. Its products include Enoxaparin Sodium Injection, which is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis; Amphadase, a protein enzyme that is prepared from a highly purified bovine testicular hyaluronidase; Cortrosyn for Injection, a diagnostic agent that is used in the screening of patients presumed to have adrenocortocal insufficiency; and prefilled disposable emergency syringes for crash cart use. The company's products also include Lidocaine HCl Jelly, a preservative-free topical local anesthetic agent that is provided in a prefilled syringe; Naloxone HCl Injection for the complete or partial reversal of narcotic depression and diagnosis of suspected acute opioid overdose; and Phytonadione Injection (Vitamin K1) for newborns. In addition, it markets its drug development pipeline and patented technologies. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California with manufacturing subsidiaries/facilities in South El Monte, California; and West Roxbury and Canton, Massachusetts.
Medicine Chemistry Pharmaceutical Pharmaceutical Products Pharmacology Medical Equipment Drug Development Active Pharmaceutical Ingredients Syringe Deep Vein Thrombosis Drug Paraphernalia Injection Heroin Hyaluronidase Lidocaine
Is AMPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 25.43
52 Week Low 17.71
Average Volume 221,922
200-Day Moving Average 21.2805
50-Day Moving Average 20.9782
20-Day Moving Average 19.995
10-Day Moving Average 20.04
Average True Range 0.5589
ADX 24.99
+DI 17.5063
-DI 23.3886
Chandelier Exit (Long, 3 ATRs ) 19.7733
Chandelier Exit (Short, 3 ATRs ) 20.6967
Upper Bollinger Band 20.7296
Lower Bollinger Band 19.2604
Percent B (%b) 0.46
BandWidth 7.347837
MACD Line -0.1887
MACD Signal Line -0.2921
MACD Histogram 0.1035
Fundamentals Value
Market Cap 920.67 Million
Num Shares 46.2 Million
EPS 0.08
Price-to-Earnings (P/E) Ratio 249.13
Price-to-Sales 3.41
Price-to-Book 2.55
PEG Ratio 2.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.13
Resistance 3 (R3) 21.26 20.98 20.93
Resistance 2 (R2) 20.98 20.68 20.92 20.86
Resistance 1 (R1) 20.46 20.49 20.32 20.33 20.80
Pivot Point 20.18 20.18 20.12 20.12 20.18
Support 1 (S1) 19.66 19.88 19.52 19.53 19.06
Support 2 (S2) 19.38 19.69 19.32 19.00
Support 3 (S3) 18.86 19.38 18.93
Support 4 (S4) 18.73